Head & Neck Cancers | Specialty

Conclusion: Key Take-Away Points and Final Thoughts

July 16th 2013

Therapies in Development for Medullary Thyroid Cancer

July 16th 2013

Treatment-Related Toxicity in Advanced MTC

July 16th 2013

Mutations and Targeted Therapies in Advanced MTC

July 16th 2013

Treating Advanced Medullary Thyroid Cancer

July 16th 2013

Multidisciplinary Treatment of Medullary Thyroid Cancer

July 16th 2013

Nonsurgical Treatment Options for Early-Stage MTC

July 16th 2013

Staging of Patients With Medullary Thyroid Cancer

July 16th 2013

Genetic Testing and Screening in Advanced MTC

July 16th 2013

Genetic Testing and Screening in Medullary Thyroid Cancer

July 16th 2013

Customizing Imaging Based on Calcitonin Levels in MTC

July 16th 2013

Introduction and Overview of MTC Diagnosis Challenges

July 16th 2013

Dr. Parsa on a Trial Analyzing G-200 for Glioblastoma

July 2nd 2013

Andrew T. Parsa MD, PhD, from the University of California, San Francisco, describes the design of a trial analyzing prophage G-200 vaccine for recurrent glioblastoma multiforme.

Genomic Alterations Characterized in Squamous Cell Cancers of the Head and Neck

June 26th 2013

Squamous cell carcinomas of the head and neck have different patterns of genetic alterations, some of which may be actionable or druggable with available agents or drugs in development.

Sorafenib Doubles PFS in Rare Thyroid Cancer

June 3rd 2013

Interim findings from a randomized, global, phase III study indicate that the multi-targeted drug sorafenib nearly doubled PFS for patients with differentiated thyroid cancer resistant to radioactive iodine therapy.

Dr. Brose on Sorafenib in RAI-Resistant Thyroid Cancer

June 2nd 2013

Marcia Brose, MD, PhD, from the Abramson Cancer Center at the University of Pennsylvania, discusses the phase III DECISION study that explored sorafenib in radioactive iodine-resistant differentiated thyroid cancer.

Partners of HPV-Positive Oropharyngeal Cancer Patients Not at Increased Risk of HPV Infection or Oral Cancer

June 2nd 2013

Patients with human papilloma virus–positive oropharyngeal cancer and their spouses may find some reassurance in a study that found that partners are no more likely to be infected by HPV than the general population.

Dr. D'Souza on Spouses of HPV-Positive Patients

June 1st 2013

Gypsyamber D‘Souza, PhD, MPH, MS, from Johns Hopkins University, discusses the prevalence of oral HPV infections in the spouses of patients with HPV-positive oropharyngeal cancer.

Dr. Sherman on Selumetinib-Enhanced Radioiodine Uptake

May 29th 2013

Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses a pilot study of selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Four Head and Neck Cancer Highlights From ASCO 2013

May 21st 2013

This article summarizes 4 abstracts that will be discussed at the 49th Annual ASCO Meeting, focused on the treatment of patients with head and neck cancer.